Safety Alerts & Recalls
What does this mean?
This recall for Daytrana (methylphenidate) transdermal system patch was issued at a warehouse and pharmacy level only. The FDA and the manufacturer have determined that any recalled product that may have been dispensed to patients does not pose a significant health risk. All Daytrana patches can continue to be used by patients. However, patches with a release liner that cannot be removed or patches that are damaged while being opened should not be used.
If you or your child uses any strength of Daytrana (methylphenidate) transdermal system patch, and you are having trouble opening or applying your Daytrana patches, you should speak to your pharmacist. If you have any other concerns about your medicine, you should speak to your doctor or pharmacist.
Noven Pharmaceutical Recalls One More Lot of Daytrana Patches
Noven Pharmaceutical and Shire US Inc. has recalled one more lot of Daytrana (methylphenidate) transdermal system patch 20 mg (2.2 mg/hr). Lot number 53995 has been recalled because the drug patches in this lot may be defective and may be difficult to peel open for use or may not stay on the skin for the right amount of time.
Daytrana contains the active ingredient methylphenidate and is commonly used in the treatment of attention deficit disorders. This recall alert only applies to lot number 53995 of Daytrana (methylphenidate) transdermal system patch 20 mg (2.2 mg/hr). No other methylphenidate products were involved in this recall.
To view the FDA notice about this recall, please visit: more information here